Works matching AU de Bono, Johann


Results: 104
    1

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    2

    Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003
    By:
    • Halabi, Susan;
    • Dutta, Sandipan;
    • Tangen, Catherine M;
    • Rosenthal, Mark;
    • Petrylak, Daniel P;
    • Thompson, Ian M;
    • Chi, Kim N;
    • Bono, Johann S De;
    • Araujo, John C;
    • Logothetis, Christopher;
    • Eisenberger, Mario A;
    • Quinn, David I;
    • Fizazi, Karim;
    • Morris, Michael J;
    • Higano, Celestia S;
    • Tannock, Ian F;
    • Small, Eric J;
    • Kelly, William Kevin
    Publication type:
    Article
    3
    4
    5

    Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 5, p. 441, doi. 10.1093/jjco/hyac015
    By:
    • Matsubara, Nobuaki;
    • Nishimura, Kazuo;
    • Kawakami, Satoru;
    • Joung, Jae Young;
    • Uemura, Hiroji;
    • Goto, Takayuki;
    • Kwon, Tae Gyun;
    • Sugimoto, Mikio;
    • Kato, Masashi;
    • Wang, Shian-Shiang;
    • Pang, See-Tong;
    • Chen, Chung-Hsin;
    • Fujita, Tomoko;
    • Nii, Masahiro;
    • Shen, Liji;
    • Dujka, Melanie;
    • Hussain, Maha;
    • Bono, Johann de
    Publication type:
    Article
    6

    Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1287, doi. 10.1093/jjco/hyab028
    By:
    • Suzuki, Hiroyoshi;
    • Castellano, Daniel;
    • Bono, Johann de;
    • Sternberg, Cora N;
    • Fizazi, Karim;
    • Tombal, Bertrand;
    • Wülfing, Christian;
    • Foster, Meredith C;
    • Ozatilgan, Ayse;
    • Geffriaud-Ricouard, Christine;
    • Wit, Ronald de
    Publication type:
    Article
    7

    A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.

    Published in:
    PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193689
    By:
    • Ferrarini, Alberto;
    • Forcato, Claudio;
    • Buson, Genny;
    • Tononi, Paola;
    • del Monaco, Valentina;
    • Terracciano, Mario;
    • Bolognesi, Chiara;
    • Fontana, Francesca;
    • Medoro, Gianni;
    • Neves, Rui;
    • Möhlendick, Birte;
    • Rihawi, Karim;
    • Ardizzoni, Andrea;
    • Sumanasuriya, Semini;
    • Flohr, Penny;
    • Lambros, Maryou;
    • de Bono, Johann;
    • Stoecklein, Nikolas H.;
    • Manaresi, Nicolò
    Publication type:
    Article
    8
    9
    10

    Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).

    Published in:
    Targeted Oncology, 2021, v. 16, n. 5, p. 613, doi. 10.1007/s11523-021-00837-y
    By:
    • Evans, Rachel;
    • Hawkins, Neil;
    • Dequen-O'Byrne, Pascale;
    • McCrea, Charles;
    • Muston, Dominic;
    • Gresty, Christopher;
    • Ghate, Sameer R.;
    • Fan, Lin;
    • Hettle, Robert;
    • Abrams, Keith R.;
    • de Bono, Johann;
    • Hussain, Maha;
    • Agarwal, Neeraj
    Publication type:
    Article
    11
    12

    Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.

    Published in:
    PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
    By:
    • Perkins, Geraldine;
    • Yap, Timothy A.;
    • Pope, Lorna;
    • Cassidy, Amy M.;
    • Dukes, Juliet P.;
    • Riisnaes, Ruth;
    • Massard, Christophe;
    • Cassier, Philippe A.;
    • Miranda, Susana;
    • Clark, Jeremy;
    • Denholm, Katie A.;
    • Thway, Khin;
    • De Castro, David Gonzalez;
    • Attard, Gerhardt;
    • Molife, L. Rhoda;
    • Kaye, Stan B.;
    • Banerji, Udai;
    • de Bono, Johann S.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.

    Published in:
    BJU International, 2017, v. 120, n. 5B, p. E30, doi. 10.1111/bju.13631
    By:
    • McDaniel, Andrew S.;
    • Ferraldeschi, Roberta;
    • Krupa, Rachel;
    • Landers, Mark;
    • Graf, Ryon;
    • Louw, Jessica;
    • Jendrisak, Adam;
    • Bales, Natalee;
    • Marrinucci, Dena;
    • Zafeiriou, Zafeiris;
    • Flohr, Penelope;
    • Sideris, Spyridon;
    • Crespo, Mateus;
    • Figueiredo, Ines;
    • Mateo, Joaquin;
    • de Bono, Johann S.;
    • Dittamore, Ryan;
    • Tomlins, Scott A.;
    • Attard, Gerhardt
    Publication type:
    Article
    23
    24

    27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.

    Published in:
    Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1251297
    By:
    • Galvan, Gloria Cecilia;
    • Friedrich, Nadine A.;
    • Das, Sanjay;
    • Daniels, James P.;
    • Pollan, Sara;
    • Dambal, Shweta;
    • Suzuki, Ryusuke;
    • Sanders, Sergio E.;
    • Sungyong You;
    • Hisashi Tanaka;
    • Yeon-Joo Lee;
    • Wei Yuan;
    • de Bono, Johann S.;
    • Vasilevskaya, Irina;
    • Knudsen, Karen E.;
    • Freeman, Michael R.;
    • Freedland, Stephen J.
    Publication type:
    Article
    25

    The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.

    Published in:
    Canadian Urological Association Journal, 2021, v. 15, n. 12, p. E623, doi. 10.5489/cuaj.7383
    By:
    • Clark, Roderick;
    • Kenk, Miran;
    • McAlpine, Kristen;
    • Thain, Emily;
    • Farncombe, Kirsten M.;
    • Pritchard, Colin C.;
    • Nussbaum, Robert;
    • Wyatt, Alexander W.;
    • de Bono, Johann;
    • Vesprini, Danny;
    • Bombard, Yvonne;
    • Lorentz, Justin;
    • Narod, Steven;
    • Kim, Raymond;
    • Fleshner, Neil
    Publication type:
    Article
    26
    27
    28
    29

    Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1213, doi. 10.1007/s00280-013-2286-7
    By:
    • Molife, L. Rhoda;
    • Rudman, Sarah M.;
    • Alam, Salma;
    • Tan, Daniel S.-W.;
    • Kristeleit, Hartmut;
    • Middleton, Gary;
    • Propper, David;
    • Bent, Liz;
    • Stopfer, Peter;
    • Uttenreuther-Fischer, Martina;
    • Wallenstein, Gudrun;
    • de Bono, Johann;
    • Spicer, James
    Publication type:
    Article
    30
    31
    32

    Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
    By:
    • Chia-Chi Lin;
    • Beeram, Muralidhar;
    • Rowinsky, Eric K.;
    • Takimoto, Chris H.;
    • Ng, Chee M.;
    • Geyer Jr., Charles E.;
    • Denis, Louis J.;
    • De Bono, Johann S.;
    • Hao, Desiree;
    • Tolcher, Anthony W.;
    • Rha, Sun-Young;
    • Jolivet, Jacques;
    • Patnaik, Amita
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.

    Published in:
    Cancers, 2021, v. 13, n. 10, p. 2334, doi. 10.3390/cancers13102334
    By:
    • Lozano, Rebeca;
    • Lorente, David;
    • Aragon, Isabel M.;
    • Romero-Laorden, Nuria;
    • Nombela, Paz;
    • Mateo, Joaquim;
    • Reid, Alison H. M.;
    • Cendón, Ylenia;
    • Bianchini, Diletta;
    • Llacer, Casilda;
    • Sandhu, Shahneen K.;
    • Sharp, Adam;
    • Rescigno, Pasquale;
    • Garcés, Teresa;
    • Pacheco, Maria I.;
    • Flohr, Penelope;
    • Massard, Christophe;
    • López-Casas, Pedro P.;
    • Castro, Elena;
    • de Bono, Johann S.
    Publication type:
    Article
    44
    45
    46

    Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

    Published in:
    Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1
    By:
    • Rhoda Molife, L.;
    • Li Yan;
    • Vitfell-Rasmussen, Joanna;
    • Zernhelt, Adriane M.;
    • Sullivan, Daniel M.;
    • Cassier, Philippe A.;
    • Eric Chen;
    • Biondo, Andrea;
    • Tetteh, Ernestina;
    • Siu, Lillian L.;
    • Patnaik, Amita;
    • Papadopoulos, Kyriakos P.;
    • De Bono, Johann S.;
    • Tolcher, Anthony W.;
    • Minton, Susan
    Publication type:
    Article
    47
    48

    Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 20, p. 3426, doi. 10.1002/cncr.35438
    By:
    • Morris, Michael J.;
    • de Bono, Johann;
    • Nagarajah, James;
    • Sartor, Oliver;
    • Wei, Xiao X.;
    • Nordquist, Luke T.;
    • Koshkin, Vadim S.;
    • Chi, Kim N.;
    • Krause, Bernd J.;
    • Herrmann, Ken;
    • Rahbar, Kambiz;
    • Vickers, Adrian;
    • Mirante, Osvaldo;
    • Ghouse, Ray;
    • Fizazi, Karim;
    • Tagawa, Scott T.
    Publication type:
    Article
    49

    Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 17, p. 3185, doi. 10.1002/cncr.34366
    By:
    • Hollebecque, Antoine;
    • Salvagni, Stefania;
    • Plummer, Ruth;
    • Niccoli, Patricia;
    • Capdevila, Jaume;
    • Curigliano, Giuseppe;
    • Moreno, Victor;
    • de Braud, Filippo;
    • de Villambrosia, Sonia Gonzalez;
    • Martin‐Romano, Patricia;
    • Baudin, Eric;
    • Arias, Marina;
    • de Alvaro, Juan;
    • Parra‐Palau, Josep L.;
    • Sánchez‐Pérez, Tania;
    • Aronchik, Ida;
    • Filvaroff, Ellen H.;
    • Lamba, Manisha;
    • Nikolova, Zariana;
    • de Bono, Johann S.
    Publication type:
    Article
    50